The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

Next-generation metagenomic sequencing test developed at UCSF proves its effectiveness in quickly diagnosing almost any kind ...

It’s difficult to fathom that the health of half the world’s population is underserved. But it’s a hard truth. There are many conditions that disproportionately impact women. Other conditions and ...

Uttar Pradesh is set to establish 16 additional solar cities as part of its initiative to improve power infrastructure and ...

The Food and Drug Administration (FDA) has approved a new presentation of Selarsdi ™ (ustekinumab-aekn), a biosimilar to Stelara ® (ustekinumab), expanding the product’s indications to include ...

Investors continued to see multiple shades of light red as biotechs continued to struggle in the wake of the postelection ...

Microorganisms—bacteria, viruses and other tiny life forms—may drive biological variation in visible life as much, if not ...

Hegseth’s selection marks a significant departure from the rest of Trump's national security team, which has largely drawn ...